The 2019 GINA Guidelines for Asthma Treatment in Adults

摘要

Establishing asthma symptom control using pharmacologic and nonpharmacologic interventions improves quality of life and prevents exacerbations in patients with asthma.The Global Initiative for Asthma 2019 guidelines provide recommendations for asthma treatment organized into five steps that correlate with disease severity. Medication options include inhaled corticosteroids (ICS), long-acting beta2 agonists, short-acting beta2 agonists (SABAs), leukotriene receptor antagonists, and oral corticosteroids. Recent data show unfavorable outcomes for SABAs used alone for as-needed treatment of symptoms of mild asthma. Guideline changes include the use of a low-dose ICS with formoterol for as-needed treatment in adults with mild asthma, or for use whenever a SABA would be used. Appropriate, effective medication regimens combined with counseling on proper inhaler technique will help patients achieve asthma-management goals.